MedPath

Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome

Not Applicable
Completed
Conditions
Fibromyalgia Syndrome
Interventions
Behavioral: Cognitive Behavioral Therapy for Groups
Behavioral: Meditation Awareness Training
Registration Number
NCT02800720
Lead Sponsor
Nottingham Trent University
Brief Summary

A Randomised Controlled Trial to evaluate the effectiveness of a Second-Generation Mindfulness-Based Intervention known as Meditation Awareness Training (MAT) for treating fibromyalgia syndrome.

Detailed Description

Background: Fibromyalgia syndrome (FMS) is a chronic pain disorder that frequently leads to poor quality of life. The need for more effective FMS treatments has prompted empirical investigations into the applications of mindfulness for treating the condition. However, studies have predominantly focused on first-generation mindfulness-based interventions (FG-MBIs). To date, a randomised controlled trial (RCT) assessing the effectiveness of a second-generation mindfulness-based intervention (SG-MBI) for treating FMS has not been undertaken. SG-MBIs are distinct from FG-MBIs because they are overtly spiritual in nature and employ (i) a greater range of (normally secularised) meditative/spiritual techniques, (ii) ethics as a key component of the taught programme, and (iii) an instructor training programme that typically requires several years of supervised mindfulness practice.

Aims: To evaluate the effectiveness of Meditation Awareness Training (MAT) - an SG-MBI - for treating FMS.

Method: Adults with FMS will receive MAT or an active control intervention known as Cognitive-Behavioural Therapy for Groups. Assessments will be performed at pre-intervention, post-intervention, and follow-up phases.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria
  • Current diagnosis of fibromyalgia syndrome
  • Aged between 18 and 65 years
  • Able to read and write using the English language
  • Available to complete an eight-week intervention and six-month follow-up assessment
Exclusion Criteria
  • Currently undergoing formal psychotherapy
  • Changes in psychopharmacology type or dosage one-month prior to intervention
  • Currently practicing mindfulness or meditation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Behavioural Therapy for GroupsCognitive Behavioral Therapy for GroupsActive Comparator Arm: 8-week CBT-based intervention
Meditation Awareness TrainingMeditation Awareness TrainingTarget Intervention Arm: 8-week meditation intervention
Primary Outcome Measures
NameTimeMethod
Short Form McGill Pain Questionnaire8 weeks

Scale Reference: Melzack (1987)

Depression Anxiety and Stress Scale8 weeks

Scale Reference: Lovibond \& Lovibond (1995)

Revised Fibromyalgia Impact Questionnaire8 weeks

Scale Reference: Bennett, Friend, Jones, Ward, Han \& Ross (2009)

Pittsburgh Sleep Quality Index8 weeks

Scale Reference: Buysse, Reynolds Monk, Berman, \& Kupfer (1989)

Secondary Outcome Measures
NameTimeMethod
Ā© Copyright 2025. All Rights Reserved by MedPath